On ECHEMI
Home > Drugs > Suzhou Tianma PHARMA Group Tianji BIO-PHARMACEUTICAL Co., Ltd.
Suzhou Tianma PHARMA Group Tianji BIO-PHARMACEUTICAL Co., Ltd.
  • Founded in:

    2000-06-21
  • Country:

    China China
  • Address:

    No. 199, Huayuan East Road, Mudu Town, Wuzhong District, Suzhou City
  • Tax NO.:

    91320506720538941C
  • Registered Funds:

    220 million yuan
  • Website:

  • Email:

Related Drugs
Thymus alpha
Name Description Content CAS NO. Registered Holders
Thymalfasin

69440-99-9 14
Compound Potassium Hydrogen Phosphate Injection
Dipotassium hydrogen phosphate (tricrystallized water) 319.5 mg/ml Potassium dihydrogen phosphate 217.7 mg/ml Osmotic pressure is approximately 7.4 mOgm/ml.
Name Description Content CAS NO. Registered Holders
Potassium hydrogen phosphate (tricrystalline water)

Phosphorus participates in sugar phosphorylation in sugar metabolism, constitutes phospholipids in membrane components, and is one of the important components of RNA, DNA and many coenzymes in cells. Phosphorus also participates in the storage, conversion and transportation of energy and the regulation of body fluid buffering function.

More

Phosphorus participates in sugar phosphorylation in sugar metabolism, constitutes phospholipids in membrane components, and is one of the important components of RNA, DNA and many coenzymes in cells. Phosphorus also participates in the storage, conversion and transportation of energy and the regulation of body fluid buffering function.

319.5mg/ml 0
Potassium Phosphate Monobasic

Phosphorus participates in sugar phosphorylation in sugar metabolism, constitutes phospholipids in membrane components, and is one of the important components of RNA, DNA and many coenzymes in cells. Phosphorus also participates in the storage, conversion and transportation of energy and the regulation of body fluid buffering function.

More

Phosphorus participates in sugar phosphorylation in sugar metabolism, constitutes phospholipids in membrane components, and is one of the important components of RNA, DNA and many coenzymes in cells. Phosphorus also participates in the storage, conversion and transportation of energy and the regulation of body fluid buffering function.

217.7mg/ml 7778-77-0 29
Citicoline Sodium Injection
Its chemical name is: monosodium salt of choline cytosine diphosphate. Molecular formula: C14H25N4NaO11P2 Molecular weight: 510.31
Name Description Content CAS NO. Registered Holders
Choline cytosine diphosphate monosodium salt

It promotes brain metabolism and improves brain circulation by reducing cerebrovascular resistance and increasing cerebral blood flow. In addition, it can enhance the function of the ascending activation system of the brainstem reticular formation, enhance the function of the pyramidal system, and improve motor paralysis, so it has a certain effect on promoting the recovery of brain function and awakening.

More

It promotes brain metabolism and improves brain circulation by reducing cerebrovascular resistance and increasing cerebral blood flow. In addition, it can enhance the function of the ascending activation system of the brainstem reticular formation, enhance the function of the pyramidal system, and improve motor paralysis, so it has a certain effect on promoting the recovery of brain function and awakening.

0
Pamidronate Disodium for Injection
The chemical name is: 3-amino-1-hydroxypropylidene-1,1-diphosphonic acid disodium pentahydrate.
Name Description Content CAS NO. Registered Holders
3-amino-1-hydroxypropylidene-1,1-diphosphonic acid disodium pentahydrate

This product is a bisphosphonate drug. In vitro and animal tests have shown that it can strongly inhibit the dissolution of hydroxyapatite and the activity of osteoclasts, and has a very significant inhibitory effect on bone absorption. It has an analgesic effect on pain caused by osteolytic bone metastasis of cancer, and can also be used to treat hypercalcemia caused by cancer.

More

This product is a bisphosphonate drug. In vitro and animal tests have shown that it can strongly inhibit the dissolution of hydroxyapatite and the activity of osteoclasts, and has a very significant inhibitory effect on bone absorption. It has an analgesic effect on pain caused by osteolytic bone metastasis of cancer, and can also be used to treat hypercalcemia caused by cancer.

0
Thymopentin
Name Description Content CAS NO. Registered Holders
Thymopentin

Extract from the above information

More

Extract from the above information

69558-55-0 41
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.